Newsroom
Probius receives grant to advance revolutionary tuberculosis diagnostic platform for resource-limited settings
Probius aims to develop AI-powered, point-of-care screening technology that eliminates sample preparation requirements and delivers accurate results in under 30 minutes.
Read More →
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development
Groundbreaking collaboration with Ginkgo and SaponiQx to to create AI-driven next-generation vaccine adjuvants for emerging threats
Read More →
Probius Expands Board of Directors, Further Enhancing Expertise in Pharma and AI
Probius announced two new members elected to the board of directors. John J. MacWilliams, Senior Advisor to the Director at LLNL and Special Assistant to ...
Read More →